<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-5307</journal-id>
<journal-title><![CDATA[Investigación y Educación en Enfermería]]></journal-title>
<abbrev-journal-title><![CDATA[Invest. educ. enferm]]></abbrev-journal-title>
<issn>0120-5307</issn>
<publisher>
<publisher-name><![CDATA[Imprenta Universidad de Antioquia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-53072019000300009</article-id>
<article-id pub-id-type="doi">10.17533/udea.iee.v37n3e09</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Validity and Reliability of the Treatment Adherence Questionnaire for Patients with Hypertension]]></article-title>
<article-title xml:lang="pt"><![CDATA[Validez e confiabilidade do questionário aderência ao tratamento em pacientes com hipertensão arterial]]></article-title>
<article-title xml:lang="es"><![CDATA[Validez y confiabilidad del cuestionario adherencia al tratamiento en pacientes con hipertensión arterial]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Esquivel Garzón]]></surname>
<given-names><![CDATA[Natalia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz Heredia]]></surname>
<given-names><![CDATA[Luz Patricia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Colombia  ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional de Colombia  ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2019</year>
</pub-date>
<volume>37</volume>
<numero>3</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-53072019000300009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-53072019000300009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-53072019000300009&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective.  To determine the validity and reliability of the Treatment Adherence Questionnaire for Patients with Hypertension (TAQPH), Spanish version, designed by Chunhua Ma et al.  Methods.  This study was carried out in the city of Ibagué (Colombia) and the test validation determined validity (face, content, and construct) and reliability. Face and content validity were conducted through expert judgment, using Fleiss&#8217; Kappa Coefficient statistical tests and modified Lawshe&#8217;s content validity index. The construct validity and the reliability test had the participation of 220 people with diagnosis of primary hypertension. Reliability was calculated through Cronbach&#8217;s alpha statistical test.  Results.  In the face validity, the instrument reported a Fleiss&#8217; Kappa index was 0.68 in comprehension, 0.76 in clarity, and 0.64 in accuracy, interpreted as a substantial agreement. The content validity index was satisfactory with 0.91; el exploratory factor analysis reported six factors with a total variance explained of 54%. Cronbach&#8217;s alpha for the total scale was 0.74.  Conclusion.  The Spanish version of the TAQPH is a valid and reliable scale to evaluate adherence to treatment in patients with primary hypertension.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Objetivo:  Determinar a validez e confiabilidade do questionário para medir a aderência ao tratamento em pacientes com hipertensão arterial (Treatment Adherence Questionnaire for Patients with Hypertension - TAQPH), versão em espanhol, desenhado por Chunhua Ma et al.  Métodos.  Estudo de validação de provas que se realizou na cidade de Ibagué (Colômbia) no qual se determinou a validez (facial, de conteúdo e de construto) e a confiabilidade. A validez facial e de conteúdo se efetuou mediante o juízo de especialistas, utilizando as provas estatísticas de Coeficiente Kappa de Fleiss e índice de Lawshe modificado. Na validez de construto e prova de confiabilidade participaram 220 pessoas com diagnóstico de hipertensão arterial. A confiabilidade se calculou mediante a prova estatística de alfa de Cronbach.  Resultados.  Na validez facial, o instrumento reportou um índice de Kappa de Fleiss de 0.68 em compreensão, 0.76 em claridade e 0.64 em precisão, interpretado como um acordo substancial. O índice de validez de conteúdo foi satisfatório com 0.91, a análise fatorial exploratório reportou seis fatores com uma variação total explicada de 54%. O alfa de Cronbach foi de 0.74 para a escala total.  Conclusão.  A versão em espanhol de TAQPH é uma escala válida e confiável para a avaliação da aderência ao tratamento em pacientes com hipertensão arterial.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo:  Determinar la validez y confiabilidad del cuestionario para medir la adherencia al tratamiento en pacientes con hipertensión arterial (Treatment Adherence Questionnaire for Patients with Hypertension - TAQPH), versión en español, diseñado por Chunhua Ma et al.  Métodos.  Estudio de validación de pruebas realizado en la ciudad de Ibagué (Colombia) en el que se determinó la validez (facial, de contenido y de constructo) y la confiabilidad. La validez facial y de contenido se efectuó mediante el juicio de expertos, utilizando las pruebas estadísticas de Coeficiente Kappa de Fleiss e índice de Lawshe modificado. En la validez de constructo y prueba de confiabilidad participaron 220 personas con diagnóstico de hipertensión arterial. La confiabilidad se calculó mediante la prueba estadística de alfa de Cronbach.  Resultados.  En la validez facial, el instrumento reportó un índice de Kappa de Fleiss de 0.68 en comprensión, 0.76 en claridad y 0.64 en precisión, interpretado como un acuerdo sustancial. El índice de validez de contenido fue satisfactorio con 0.91. El análisis factorial exploratorio reportó seis factores con una varianza total explicada de 54%. El alfa de Cronbach fue de 0.74 para la escala total.  Conclusión.  La versión en español del TAQPH es una escala válida y confiable para la evaluación de la adherencia al tratamiento en pacientes con hipertensión arterial.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[essential hypertension]]></kwd>
<kwd lng="en"><![CDATA[treatment adherence and compliance]]></kwd>
<kwd lng="en"><![CDATA[surveys and questionnaires]]></kwd>
<kwd lng="en"><![CDATA[psychometrics]]></kwd>
<kwd lng="en"><![CDATA[validation studies.]]></kwd>
<kwd lng="pt"><![CDATA[esencial]]></kwd>
<kwd lng="pt"><![CDATA[cooperação e adesão ao tratamento]]></kwd>
<kwd lng="pt"><![CDATA[inquéritos e questionário]]></kwd>
<kwd lng="pt"><![CDATA[psicometria]]></kwd>
<kwd lng="pt"><![CDATA[estudos de validação.]]></kwd>
<kwd lng="es"><![CDATA[hipertensión esencial]]></kwd>
<kwd lng="es"><![CDATA[cumplimiento y adherencia al tratamiento]]></kwd>
<kwd lng="es"><![CDATA[encuestas y cuestionarios]]></kwd>
<kwd lng="es"><![CDATA[psicometría]]></kwd>
<kwd lng="es"><![CDATA[estudios de validación.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="book">
<collab>World Health Organization.</collab>
<source><![CDATA[Global Status Report on Alcohol and Health]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Genève ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud.</collab>
<source><![CDATA[Información general sobre la hipertensión en el mundo. Una enfermedad que mata en silencio, una crisis de salud pública mundial]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piette]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Beard]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rosland]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[McHorney]]></surname>
<given-names><![CDATA[CA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Beliefs that influence cost-related medication non-adherence among the &#8220;haves&#8221; and &#8220;have nots&#8221; with chronic diseases. Patient Prefer.]]></article-title>
<source><![CDATA[Adherence]]></source>
<year>2011</year>
<volume>5</volume>
<page-range>389-96.</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morrissey]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Durand]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Nieuwlaat]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Navarro]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Haynes]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness and content analysis of interventions to enhance medication adherence and blood pressure control in hypertension: A systematic review and meta-analysis.]]></article-title>
<source><![CDATA[Psychol. Heal.]]></source>
<year>2017</year>
<volume>32</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1195-232.</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conn]]></surname>
<given-names><![CDATA[VS]]></given-names>
</name>
<name>
<surname><![CDATA[Ruppar]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Chase]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Enriquez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cooper]]></surname>
<given-names><![CDATA[PS.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interventions to Improve Medication Adherence in Hypertensive Patients: Systematic Review and Meta-analysis.]]></article-title>
<source><![CDATA[Curr. Hypertens. Rep.]]></source>
<year>2015</year>
<volume>17</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>94</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pittman]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Tao]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Stettin]]></surname>
<given-names><![CDATA[GD.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antihypertensive medication adherence and subsequent healthcare utilization and costs.]]></article-title>
<source><![CDATA[Am. J. Manag. Care.]]></source>
<year>2010</year>
<volume>16</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>568-76.</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vrijens]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Antoniou]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Burnier]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[De]]></surname>
<given-names><![CDATA[Sierra A]]></given-names>
</name>
<name>
<surname><![CDATA[Volpe]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current Situation of Medication Adherence in Hypertension.]]></article-title>
<source><![CDATA[Front. Pharmacol.]]></source>
<year>2017</year>
<volume>8</volume>
<page-range>10</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jimmy]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Jose]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient Medication Adherence : Measures in Daily Practice.]]></article-title>
<source><![CDATA[Oman Med. J.]]></source>
<year>2011</year>
<volume>26</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>155-9.</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morisky]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Ang]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Krousel-Wood]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[HJ.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictive Validity of A Medication Adherence Measure in an Outpatient Setting.]]></article-title>
<source><![CDATA[J. Clin. Hypertens. (Greenwich).]]></source>
<year>2008</year>
<volume>10</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>348-54.</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Svarstad]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Chewning]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Sleath]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Claesson]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence.]]></article-title>
<source><![CDATA[Patient Educ. Couns.]]></source>
<year>1999</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>113-24.</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hill]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bone]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Levine]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale.]]></article-title>
<source><![CDATA[Prog. Cardiovasc. Nurs.]]></source>
<year>2000</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>90-6.</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bayarre]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Grau]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of MBG Questionnaire (Martin-Bayarre-Grau) for the evaluation of therapy adherence in blood hypertension patients.]]></article-title>
<source><![CDATA[Rev. Cubana Salud Pública]]></source>
<year>2008</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wetzels]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Nelemans]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wijk van]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Broers]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Schouten]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Prins]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Determinants of poor adherence in hypertensive patients: Development and validation of the &#8216;&#8220;Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire.&#8221;&#8217;]]></article-title>
<source><![CDATA[Patient Educ. Couns.]]></source>
<year>2006</year>
<volume>64</volume>
<page-range>151-8.</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lahdenperä]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Kyngäs]]></surname>
<given-names><![CDATA[HA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of a scale to assess the compliance of hypertensive patients.]]></article-title>
<source><![CDATA[Int. J. Nurs. Stud.]]></source>
<year>2003</year>
<volume>40</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>677-84.</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="book">
<collab>World Health Organization.</collab>
<source><![CDATA[Adherence to Long-Term Therapies. Evidence for action.]]></source>
<year>2003</year>
<edition>1st ed</edition>
<publisher-loc><![CDATA[Geneva, Switzerland ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[You]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Xing]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and psychometric evaluation of the Treatment Adherence Questionnaire for Patients with Hypertension.]]></article-title>
<source><![CDATA[J. Adv. Nurs.]]></source>
<year>2012</year>
<volume>68</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1402-13.</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Landis]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Koch]]></surname>
<given-names><![CDATA[GG.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The measurement of observer agreement for categorical data.]]></article-title>
<source><![CDATA[Biometrics]]></source>
<year>1977</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>159-74.</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tristán-López]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Modificación al modelo de Lawshe para el dictamen cuantitativo de la validez de contenido de un instrumento objetivo.]]></article-title>
<source><![CDATA[Av. Medición.]]></source>
<year>2003</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>37-48.</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gorsuch]]></surname>
<given-names><![CDATA[RL.]]></given-names>
</name>
</person-group>
<source><![CDATA[Factor analysis.]]></source>
<year>1983</year>
<edition>2nd Ed.</edition>
<publisher-loc><![CDATA[Hillsdale, New Jersey ]]></publisher-loc>
<publisher-name><![CDATA[Lawrence Erlbaum]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bandalos]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Finney]]></surname>
<given-names><![CDATA[SJ.]]></given-names>
</name>
</person-group>
<source><![CDATA[Factor Analysis: Exploratory and Confirmatory. In: Hancock GR, Mueller RO, editors. Reviewer&#8217;s Guide to Quantitative Methods.]]></source>
<year>2010</year>
<page-range>P. 449.</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Routledge]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<label>21.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tavakol]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dennick]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Making sense of Cronbach&#8217;s alpha.]]></article-title>
<source><![CDATA[Int. J. Med. Educ.]]></source>
<year>2011</year>
<volume>2</volume>
<page-range>53-.</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Streiner]]></surname>
<given-names><![CDATA[DL.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Starting at the Beginning: An Introduction to Coefficient Alpha and Internal Consistency.]]></article-title>
<source><![CDATA[J. Pers. Assess.]]></source>
<year>2003</year>
<volume>80</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>99-103.</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dehghan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dehghan-Nayeri]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Iranmanesh]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension.]]></article-title>
<source><![CDATA[ARYA Atheroscler.]]></source>
<year>2016</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>76-86.</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
